DEVICE CATEGORY · OCM
Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation
Surgical cardiac ablation for the treatment of atrial fibrillation.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Synergy Ablation SystemP100046/S021 | AtriCure, Inc. | PMA supplement | Sep 24, 2026 | FDA |
EPi- Sense ST Coagulation SystemP200002/S015 | AtriCure, Inc. | PMA supplement | Sep 24, 2026 | FDA |
Synergy Ablation SystemP100046/S020 | AtriCure, Inc. | PMA supplement | May 6, 2026 | FDA |
| AtriCure, Inc. | PMA supplement | May 6, 2026 | FDA | |
EPi-Sense ST Coagulation SystemP200002/S013 | AtriCure, Inc. | PMA supplement | Nov 14, 2025 | FDA |
EPi-Sense Guided Coagulation SystemP200002/S012 | AtriCure, Inc. | PMA supplement | Oct 7, 2025 | FDA |
| AtriCure, Inc. | PMA approval | Apr 28, 2021 | FDA | |
| AtriCure, Inc. | PMA approval | Dec 14, 2011 | FDA |
Source information
Follow the FDA links to view the original records.





